{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:30:54Z","timestamp":1757619054143,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 63-year-old female who presented with bilateral panuveitis suspicious for a neoplastic etiology, underwent diagnostic pars plana vitrectomy of her right eye. Cytology was negative and flow cytometry did not reveal evidence of B-cell lymphoma. PCR revealed T-cell Receptor Gamma (TRG) clonal peaks and NGS demonstrated mutations in the <jats:italic>DNMT3A<\/jats:italic> and <jats:italic>MAP2K1<\/jats:italic> genes. Systemic oncologic surveillance was inconclusive, but flow cytometry of peripheral blood revealed an expansion of aberrant T-cells. Subsequent vitreous biopsy of the fellow eye revealed identical TRG clonal peaks, and T-cell flow cytometry immunophenotype results were similar to those in peripheral blood, with a TRBC1 monotypic pattern, consistent with a diagnosis of bilateral T-cell vitreoretinal lymphoma. T-cell vitreoretinal lymphomas present a diagnostic challenge, which can often delay treatment. This case highlights the usefulness of molecular techniques, such as PCR, flow cytometry and NGS, to complement conventional diagnostic techniques.<\/jats:p>","DOI":"10.1038\/s41698-025-00870-4","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T12:00:32Z","timestamp":1752840032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular analysis of bilateral T-cell vitreoretinal lymphoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Matias","family":"Soifer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3720-6320","authenticated-orcid":false,"given":"Sonny","family":"Caplash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-8366","authenticated-orcid":false,"given":"Rajesh C.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance M.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Papanicolau-Sengos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Bellur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Kodati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00417-004-0973-0","volume":"242","author":"SE Coupland","year":"2004","unstructured":"Coupland, S. E., Heimann, H. & Bechrakis, N. E. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes. Arch. Clin. Exp. Ophthalmol. 242, 901\u2013913 (2004).","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","volume":"131","author":"SD Levasseur","year":"2013","unstructured":"Levasseur, S. D., Wittenberg, L. A. & White, V. A. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA. Ophthalmol. 131, 50\u201355 (2013).","journal-title":"JAMA. Ophthalmol."},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"20210916","DOI":"10.3390\/ijms22189992","volume":"22","author":"DA Balikov","year":"2021","unstructured":"Balikov, D. A. et al. Comparative molecular analysis of primary central nervous system lymphomas and matched vitreoretinal lymphomas by vitreous liquid biopsy. Int. J. Mol. Sci. 22, 20210916 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00417-005-0138-9","volume":"244","author":"K Jahnke","year":"2006","unstructured":"Jahnke, K. et al. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial. Graefes Arch. Clin. Exp. Ophthalmol. 244, 663\u2013669 (2006).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.survophthal.2021.03.004","volume":"66","author":"V Raval","year":"2021","unstructured":"Raval, V. et al. Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management. Surv. Ophthalmol. 66, 1009\u20131020 (2021).","journal-title":"Surv. Ophthalmol."},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/08820530500350498","volume":"21","author":"JY Choi","year":"2006","unstructured":"Choi, J. Y., Kafkala, C. & Foster, C. S. Primary intraocular lymphoma: a review. Semin Ophthalmol 21, 125\u2013133 (2006).","journal-title":"Semin Ophthalmol"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9394(14)70828-1","volume":"124","author":"JL Davis","year":"1997","unstructured":"Davis, J. L., Viciana, A. L. & Ruiz, P. Diagnosis of intraocular lymphoma by flow cytometry. Am. J. Ophthalmol. 124, 362\u2013372 (1997).","journal-title":"Am. J. Ophthalmol."},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/bjo.75.11.698","volume":"75","author":"BC Erny","year":"1991","unstructured":"Erny, B. C. et al. Intraocular involvement with subretinal pigment epithelium infiltrates by mycosis fungoides. Br. J. Ophthalmol. 75, 698\u2013701 (1991).","journal-title":"Br. J. Ophthalmol."},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/archopht.1989.01070020419047","volume":"107","author":"SH Goldey","year":"1989","unstructured":"Goldey, S. H. et al. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch. Ophthalmol. 107, 1349\u20131353 (1989).","journal-title":"Arch. Ophthalmol."},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3109\/09273948.2016.1139733","volume":"25","author":"F Chaput","year":"2017","unstructured":"Chaput, F. et al. Intraocular T-cell lymphoma: clinical presentation, diagnosis, treatment, and outcome. Ocul. Immunol. Inflamm. 25, 639\u2013648 (2017).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0161-6420(13)31398-0","volume":"100","author":"T Kohno","year":"1993","unstructured":"Kohno, T. et al. Ocular manifestations of adult T-cell leukemia\/lymphoma. A clinicopathologic study. Ophthalmology 100, 1794\u20131799 (1993).","journal-title":"Ophthalmology"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","volume":"29","author":"D Carbonell","year":"2021","unstructured":"Carbonell, D. et al. Consensus recommendations for the diagnosis of vitreoretinal lymphoma. Ocul. Immunol. Inflamm. 29, 507\u2013520 (2021).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","volume":"4","author":"JS Pulido","year":"2018","unstructured":"Pulido, J. S. et al. The diagnosis and treatment of primary vitreoretinal lymphoma: a review. Int. J. Retin Vitreous 4, 18 (2018).","journal-title":"Int. J. Retin Vitreous"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","volume":"16","author":"CC Chan","year":"2011","unstructured":"Chan, C. C. et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 16, 1589\u20131599 (2011).","journal-title":"Oncologist"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.3390\/ijms12095684","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int. J. Mol. Sci. 12, 5684\u20135697 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00417-003-0749-y","volume":"241","author":"SE Coupland","year":"2003","unstructured":"Coupland, S. E. et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 241, 860\u2013870 (2003).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"870_CR17","first-page":"117","volume":"110","author":"JL Davis","year":"2012","unstructured":"Davis, J. L. et al. Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis). Trans. Am. Ophthalmological Soc 110, 117\u2013129 (2012).","journal-title":"Trans. Am. Ophthalmological Soc"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","volume":"36","author":"FC Eberle","year":"2012","unstructured":"Eberle, F. C. et al. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am. J. Surg. Pathol. 36, 716\u2013725 (2012).","journal-title":"Am. J. Surg. Pathol."},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"20220516","DOI":"10.3390\/cancers14102457","volume":"14","author":"G Froyen","year":"2022","unstructured":"Froyen, G. et al. Diagnostic validation of a comprehensive targeted panel for broad mutational and biomarker analysis in solid tumors. Cancers 14, 20220516 (2022).","journal-title":"Cancers"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jmoldx.2022.01.008","volume":"24","author":"B Wei","year":"2022","unstructured":"Wei, B. et al. Evaluation of the TruSight Oncology 500 assay for routine clinical testing of tumor mutational burden and clinical utility for predicting response to pembrolizumab. J. Mol. Diagn. 24, 600\u2013608 (2022).","journal-title":"J. Mol. Diagn."},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"20210605","DOI":"10.3390\/ijms22116099","volume":"22","author":"AK Cani","year":"2021","unstructured":"Cani, A. K. et al. Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy. Int J. Mol. Sci. 22, 20210605 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.survophthal.2008.02.004","volume":"53","author":"GA Levy-Clarke","year":"2008","unstructured":"Levy-Clarke, G. A. et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv. Ophthalmol. 53, 285\u2013295 (2008).","journal-title":"Surv. Ophthalmol."},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/leu.2017.89","volume":"31","author":"AC Kramer","year":"2017","unstructured":"Kramer, A. C. et al. Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia 31, 2479\u20132490 (2017).","journal-title":"Leukemia"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/gcc.22247","volume":"54","author":"DS Nelson","year":"2015","unstructured":"Nelson, D. S. et al. MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54, 361\u2013368 (2015).","journal-title":"Genes Chromosomes Cancer"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/1535-7163.MCT-13-0667","volume":"13","author":"Y Narita","year":"2014","unstructured":"Narita, Y. et al. Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model. Mol. Cancer Ther. 13, 823\u2013832 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1200\/JCO.2010.33.2312","volume":"29","author":"N Wagle","year":"2011","unstructured":"Wagle, N. et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J. Clin. Oncol. 29, 3085\u20133096 (2011).","journal-title":"J. Clin. Oncol."},{"key":"870_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1309\/835B04QXGNNFNRJU","volume":"120","author":"RC Beck","year":"2003","unstructured":"Beck, R. C. et al. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies. Am. J. Clin. Pathol. 120, 785\u2013794 (2003).","journal-title":"Am. J. Clin. Pathol."},{"key":"870_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1309\/AJCPPT93VZMAREHK","volume":"137","author":"P Tembhare","year":"2012","unstructured":"Tembhare, P. et al. Flow cytometric immunophenotypic assessment of T-cell clonality by vbeta repertoire analysis in fine-needle aspirates and cerebrospinal fluid. Am. J. Clin. Pathol. 137, 220\u2013226 (2012).","journal-title":"Am. J. Clin. Pathol."},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ajcp\/aqy173","volume":"151","author":"ND Novikov","year":"2019","unstructured":"Novikov, N. D. et al. Utility of a simple and robust flow cytometry assay for rapid clonality testing in mature peripheral T-cell lymphomas. Am. J. Clin. Pathol. 151, 494\u2013503 (2019).","journal-title":"Am. J. Clin. Pathol."},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cyto.b.21881","volume":"100","author":"H Berg","year":"2021","unstructured":"Berg, H. et al. Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytom. Part B Clin. Cytom 100, 361\u2013369 (2021).","journal-title":"Cytom. Part B Clin. Cytom"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00870-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:13:47Z","timestamp":1757254427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-00870-4","relation":{},"ISSN":["2397-768X"],"issn-type":[{"type":"electronic","value":"2397-768X"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"A consent for publication was received by the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"244"}}